INTRODUCTION
0002 This invention relates to the field of detecting a genetic marker of T-cell malignancies. The invention pro vides compositions and methods useful for detecting clonal T-cell receptor gene arrangements. By using PCR and tem poral temperature gradient gel electrophoresis (TTGE), the clonality of T-cell populations in a Sample can be deter mined.
BACKGROUND OF THE INVENTION
0003. The following discussion of the background of the invention is merely provided to aid the reader in understand ing the invention and is not admitted to describe or constitute prior art to the present invention. 0004 T lymphocytes are important players in the immune response of mammalian organisms. Each T-lym phocyte has on its Surface a molecule, known as the T-cell receptor ("TCR") that exhibits a specificity of binding to a target antigen that is similar to the Specificity of binding exhibited by antibodies, and TCR is encoded by genes having an organization Similar to that of antibody genes. 0005. During normal T-cell development, each TCR gene (C., f, Y and 8) can rearrange, leading to highly diverse TCR proteins. Among the four TCR gene types, the TCR-Y genes are the first to rearrange. During the rearrangement of each TCR gene, one of its different variable (V) regions combines with one of its different joining (J) regions. In the TCR-y gene, a few nucleotides (N region) are also inserted ran domly into the VJ regions by terminal nucleotidyl trans ferase (TdT), resulting in an increased sequence diversity in the TCR-Y gene as compared to the other TCR genes. It is believed that each mature T-cell possesses an individual Sequence of rearranged TCR genes. 0006 T-cell malignancies can present to the physician with Strikingly similar clinical patterns to Simple reactive, or inflammatory, diseases. T-cell malignancies, however, can be differentiated from reactive diseases by the presence in malignancy of an overgrowth of a Single, clonal, T-cell population. Therefore, analysis of TCR gene rearrangement, and particularly the TCR-Y gene, is of practical value in determining the clonality T-cell populations for the diagno sis and prognosis of T-cell malignancies (Flug et al., Proc Natl Acad Sci USA. 82: 3460-3464, 1985; Yanagi et al., Nature 308: 145-149, 1984; Waldmann et al., N Engl J Med 3.13: 776-783, 1985; Raulet, Annu Rev Immunol. 7: 175 207, 1989; Theodorou et al., Blood 86: 305-310,1995 Dec. 9, 2004 hybridization can be time-consuming and labor-intensive, and requires the use of large amounts of high molecular weight DNA and radioactivity, polymerase chain reaction (PCR)-based techniques have become more popular in research and clinical laboratories. These techniques can also permit the use of DNA extracted from formalin fixed par affin-embedded specimens and are more rapid than hybrid ization approaches (Theodorou et al., Blood 86: 305-310, 1995; Murphy et al., J Cutan Pathol. 27: 228-234, 2000 ; Anderson et al., J. Cutan Pathol. 26: 176-182, 1999; Wood et al., J Invest Dermatol. 103: 34-41, 1994 , Menke et al., Electrophoresis 16: 733-738, 1995 Bourguin et al., Proc Natl Acad Sci USA. 87: 8536-8540, 1990) . 0008 PCR amplification of one or more TCR genes from non-malignant peripheral blood or lymph node tissue Samples generates a mixture of multiple DNA molecules differing in Size and/or base pair composition. Because the combinatorial and junctional diversity in TCR gene rear rangement is limited, the amplified products may be of Similar length. Thus, the limited diversity may result in false clonal bands when analyzed by a Standard gel electrophore sis methods that separate DNA molecules based solely on size (Theodorou et al., Blood 86: 305-310,1995; Menke et al., Electrophoresis 16: 733-738, 1995) , and can occur when using either Southern blotting hybridization (which is based on agarose gel electrophoresis) or PCR followed by standard polyacrylamide gel electrophoresis (PAGE). Furthermore, due to the poor resolution of Standard gel electrophoresis methods, DNA bands of low frequency clones may be lost in the polyclonal background "Smear, leading to difficult in interpreting the results of Such an analysis. 0009 Recently, electrophoresis techniques that resolve DNA molecules based on size and base pair composition have been explored, such as polymorphism (SSCP) (Murphy et al., J Cutan Pathol. 27. 228-234, 2000) , denaturing gradient gel electrophoresis (DGGE) (Theodorou et al., Blood 86: 305-310, 1995; Anderson et al., J. Cutan Pathol. 26: 176-182, 1999; Wood et al., J Invest Dermatol. 103: 34-41, 1994 ) and temperature gradient gel electrophoresis (TGGE) (Menke et al., Electrophoresis 16: 733-738, 1995) .
To maximize the resolution of SSCP, however, more than one electrophoretic condition is often needed (Orita et al., Genomics 5: 874-879, 1989) . Moreover, although DGGE has been gaining popularity to determine the clonality of T-cell populations (Theodorou et al., Blood 86: 305-310, 1995; Anderson et al., J. Cutan Pathol. 26: 176-182, 1999; Wood et al., J. Invest Dermatol. 103:34-41, 1994) , the difficulty in preparing denaturing gradient polyacrylamide gel limits the routine usage of this technique in clinical laboratories. Similarly, the routine use of TGGE in clinical laboratories is also limited because of its reliance on an instrument that is both expensive and difficult to maintain. (Menke et al. Electrophoresis. 16:733-738, 1995; Alkan et al. Arch Pathol Lab Med. 125:202-207, 2001 ). 0010 Thus, there remains in the art a need for methods and compositions that can reproducibly and economically resolve clonal T-cell receptor populations in patient Samples.
SUMMARY OF THE INVENTION
0011. In the present invention provides methods and compositions to determine the clonality of T-cell receptor populations present in a Sample. Temporal temperature gradient gel electrophoresis (TTGE), developed by Yoshino et al. (Nucleic Acids Res. 19:3153, 1991) and Chen et al. (Clin Chem. 45:1162 -1167 , 1999 , can be used to detect the presence or absence of a clonal TCR gene rearrangement. In the instant methods, target DNA is electrophoresed in a denaturing gel, and the temperature of the gel is increased gradually and uniformly acroSS a range in which differences in the base composition of the target DNA are resolved. Because the gel itself is not a gradient gel, and because the temperature gradient is temporal rather than Spatial acroSS the gel, the instant methods can be performed in an eco nomical fashion. In addition, the resulting DNA band pat terns can be easily interpreted and quality controlled in a clinical laboratory Setting. 0012. In accordance with the present invention, TTGE can detect clonal TCR (e.g., TCR-Y) gene arrangements present in a Sample at concentrations as low as one malig nant T-cell among 100 normal cells. Additionally, DNA can be extracted from Stored Samples (e.g., Samples Stored at 4 C. for up to 7 days and at room temperature for up to 4 days) and used for PCR amplification to generate gene amplicons for TCR gene rearrangement analysis by TTGE without Significant variability of the band pattern and Signal inten sity. Thus, the invention provides simple, accurate and Sensitive techniques to diagnose and monitor patients with T-cell malignancies. 0013 In a first aspect, the instant invention relates to methods for determining the clonality of a T-cell receptor (TCR) rearrangement in a Sample comprising the steps of extracting nucleic acids from the Sample, amplifying the nucleic acids, preferably by polymerase chain reaction with one or more TCR specific primers to provide one or more TCR DNA fragments; and analyzing amplified TCR DNA fragments using an electrophoretic gel by temporal tempera ture gradient gel electrophoreis (TTGE). The present of one or more discrete bands in the electrophoretic gel indicates the presence of a clonal TCR rearrangement. 0.014. In certain embodiments, the electrophoretic profile of a test Sample can be compared to one or more control Samples (e.g., a negative control Sample obtained from a Sample not containing a clonal T-cell rearrangement), and the presence of one or more discrete bands in the test Sample that are not present in the control Sample(s) indicates the presence of a clonal TCR rearrangement. 0.015 AS used herein, the term "T-cell receptor" refers to the antigen-recognition molecules present on the Surface of T-cells. See, e.g., Garcia et al., Rev. Immunogenet. 1999;1(1): 75-90. As indicated above, during normal T-cell develop, each of the four TCR genes, C, B, Y and Ö, can rearrange leading to highly diverse TCR proteins. See, e.g., Gill and Gulley, Hematol. Oncol. Clin. North Am. 1994 August;8(4):751-70; Greiner, Am. J. Pathol. 1999 Janu ary; 154(1):7-9. 0016. The term "clonality" as used herein regarding T-cells refers to the expansion of a single population of T-cells in a Sample. Such a clonal expansion occurs when, for example, T-cell populations are challenged by an anti gen. In response, that population of T-cells that recognize the antigen increase in number. In more dramatic fashion, clonal expansion occurs in certain T-cell malignancies, in which a Single T-cell population expands beyond normal levels due to a loSS of growth control in a T-cell. In certain embodi Dec. 9, 2004 ments, clonality is determined by analyzing a TCR-C, TCR B, TCR-Y and/or TCR-8 gene rearrangement using PCR amplification with two or more appropriate primer Sequences for the gene(s) of interest, and temporal tempera ture gradient gel electrophoresis, as described herein 0017. The term "amplify" with respect to nucleic acid Sequences refers to methods that increase the representation of a population of nucleic acid Sequences in a Sample. Nucleic acid amplification methods, such as PCR, isother mal methods, rolling circle methods, etc., are well known to the skilled artisan. See, e.g., Saiki, "Amplification of however, other nucleic acids (e.g., mRNA) may also be extracted and amplified to perform the clonality assays of the present invention. 0019. In certain embodiments, nucleic acids can be amplified using PCR with TCR-specific primers, i.e., oligo nucleotides Suitable for amplifying Specific regions of TCR.
Preferred primers are Vy1-8 (5'-AGGGTTGTGTTG GAAATCAGG-3") (SEQ ID NO:3) for V region and Jy1/2 (5'-CGCCCGCCGCGCCCCGCGCCCGTCCCGC CGCCCCCCTGTTCCACTGCCAAA GAGTTTCTT-3) (SEQ ID NO:4) for J region. The primer sequence for JY1/2 for J region is a GC-clamp region designed to introduce a high melting point domain at one end of the PCR amplicon, facilitating analysis by TTGE. Additional suitable primers are described below in the figures. 0020. As used herein, the term temporal temperature gradient gel electrophoresis ("TTGE") refers to electro phoresis methods in which Samples are run in a gel matrix, e.g., a polyacrylamide gel, and the temperature of the gel is altered in a time-dependent fashion as the Samples are migrating through the gel. In Such a gel, the relative mobility of a DNA sample is based on its relative thermal stability. Thus, by careful selection of the temperature profile of the gel, the migration of molecules in the Sample can be altered as the temperature changes. For example, DNA molecules can be run in the gel matrix using a temperature profile in which certain base pairs in the molecules "melt," that is, where the temperature is Sufficient to disrupt the hydrogen bonding in the Watson-Crick base pairs. The skilled artisan will understand that different DNA sequences will have different relative thermal Stability; e.g., A-T-rich regions will melt at a lower temperature than GC-rich regions. As the base pairs melt, the molecular structure of the DNAbecomes locally "open, resulting in a change in mobility. 0021. The term "gel" as used herein refers to any semi Solid medium capable of Supporting a fluid phase for Sepa rating nucleic acids based on size and melting temperature profile of the individual nucleic acid molecules when an electric field is placed acroSS the medium. Gels may include Starch, acrylamide, agarose, or mixtures of these materials, and may be a single concentration, or gradient. The elec trolyte used to Separate materials in a gel may be either continuous or discontinuous. In preferred embodiments, the gel is an acrylamide gel of a Single concentration through out, and the elecrolyte is a continuous buffer System. 0022 Typical electrophoresis gels comprise a plurality of channels, known to the artisan as "lanes," in which indi vidual Samples (and/or controls) may be loaded and run in parallel on the same gel. Because all Such Samples are exposed to essentially the same electrophoresis conditions, the characteristics of Samples (and/or controls) in different lanes can be directly compared. Molecules that migrate to the same location in the gel appear, upon detection, as "bands; i.e., a line of material about the width of the lane and having a characteristic height (often about 0.2 to about 5 mm). Bands on Separate gels can often be compared by determining the relative location of the band in relation to controls ("standards") that have been run in each of the Separate gels. 0023 Material will migrate to the same location in the gel for a number of reasons, depending on the type of electro phoresis used. For example, in isoelectric focusing, material will migrate to the same location if the material has the same isoelectric point. As discussed herein, in TTGE, DNA mol ecules will migrate at the same rate, and thus migrate to the Same location in a gel, if the molecules have the same relative thermal stability. 0024. As used herein, the term "the presence one or more discrete bands' refers to a signal that is obtained from molecules that migrate to a discrete location in an electro phoretic gel. For example, a clonal T-cell rearrangement in a malignancy can be detected as a population of DNA molecules that migrate at identical rates through a gel, Such that they appear as a single "band' upon detection, e.g., by gel Staining techniques well known in the art. AS discussed herein, because genes are "multiallelic," that is, there are two alleles of each gene, one on each chromosome of a chromosome pair, a clonal T-cell rearrangement may appear as more than one discrete band in Such a gel. 0026. Additionally, a discrete band can be discriminated from a diffuse "smear' within a gel by a sharp fall off in intensity present at the band boundary, where Signal inten sity rapidly falls to background. This rapid fall-off results in a band that is between Ao" and twice the height of a band obtained from a positive Standard run in the same gel, while diffuse Staining results in a band that is greater than twice the height of the positive Standard. 0027. The term "sample" as used herein refers to any liquid or solid material believed to comprise T-cells. In preferred embodiments, a Sample is a tissue sample from an animal, most preferably a human. Preferred Sample tissues of the instant invention include, but are not limited to, plasma, Serum, whole blood, blood cells, lymphatic fluid, lymphatic cells, lymph node tissue, cerebroSpinal fluid, and Dec. 9, 2004 skin or other organs (e.g., biopsy material). Such sample tissues may or may not be fixed, e.g., by formalin, and/or embedded for Sectioning, e.g., in paraffin. 0028. The term "patient sample" as used herein refers to a Sample from an animal, most preferably a human, Seeking diagnosis or treatment of a disease. 0029. In another aspect, the present invention relates to methods for diagnosing a patient Suspected of having a neoplastic T-cell disease. In these methods, a clonal expan Sion of a T-cell population is determined by analyzing the clonality of TCR gene rearrangements in a Sample. A positive indication of Such a clonal expansion is indicative of a neoplastic T-cell disease. These methods preferably comprise obtaining a Sample from a patient and determining whether a clonal TCR gene rearrangement is present in the Sample using TTGE, wherein the presence of a discrete band in the electrophoretic gel indicates the presence of a clonal TCR rearrangement.
0030. In certain embodiments, these methods can be used to compare two or more lesions in a patient having a neoplastic T-cell disease. AS used herein, the term "lesion' refers to diseased tissue in a patient. In these embodiments, a Sample from a first lesion and a Second lesion in the patient can be obtained, and each Sample can be analyzed for the presence or absence of identical clonal TCR gene rearrange ments in each Sample. In various preferred embodiments, the lesions can be obtained from the same disease focus, but at different times during the course of a disease (e.g., before and after a treatment regimen); or from different disease foci at the same or different times. AS used herein, the term "disease focus' refers to a spatially unique location in a patient that harbors diseased tissue. 0031. In yet another aspect, the present invention relates to methods and compositions for designing a treatment regimen. In these methods, the presence or amount of a clonal TCR gene rearrangement in a patient following a Selected treatment(s) can be used to assess the Success or lack thereof in the treatment regimen. Such methods can also compare the relative presence or amount of a clonal TCR gene rearrangement in a patient before and after Such a treatment regimen. 0032 Similarly, the present invention also relates to methods and compositions for Screening therapeutic com pounds. In these methods, the presence or amount of a clonal TCR gene rearrangement in a patient following administra tion of one or more compounds can be used to assess therapeutic efficacy. Such methods can also compare the relative presence or amount of a clonal TCR gene rearrange ment in a patient before and after administration of one or more compounds. 0033. In accordance with still another aspect, the present invention relates to methods for preparing a Substantially pure nucleic acid migration marker for use in a TTGE gel, and to the nucleic acid migration markers themselves. Pref erably, Such a marker can be prepared from one or more DNA fragments having known migration rates in the TTGE gel. For example, a standard DNA ladder for TTGE analysis can be made by amplifying one or more DNA fragments containing known TCR rearrangements using TCR-specific primers. Alternatively, Synthetic methods well known to the skilled artisan can be used to prepare Such a marker.
0034. In either case, the DNA fragments can then be inserted into a plasmid cloning vector. The plasmid can then be used to transform a cell population in order to amplify the number of plasmid molecules, thus preparing "plasmid amplicons.' Isolated plasmids and/or amplicons can be used to generate a large number of DNA migration markers, e.g., by PCR using TCR-specific primers. 0035) In certain embodiments, the plasmids and/or ampli cons containing known TCR rearrangements can be Sub jected to PCR in parallel with samples to be analyzed for clonal TCR rearrangement, using identical conditions and TCR-specific primers. In these embodiments, the plasmid amplicons can both provide both DNA migration markers and a positive PCR control, in which the presence of the DNA migration marker in the TTGE gel confirms that the PCR reaction Successfully occurred in the Samples. 0.036 Mixtures of a plurality of TTGE migration markers can provide multiple reference points in a TTGE gel. Thus, in preferred embodiments, a composition of migration mark erS comprises 2, 3, 4, 5, 6, 7, 10, and 20 different migration markers in a buffer suitable for loading on a TTGE gel. 0037. The term "migration marker" as used herein refers to a nucleic acid Sequence known to migrate with a certain relative mobility in a TTGE gel and form a discrete band in the gel. The term "Substantially pure' as used herein regard ing TTGE migration markers refers to a purity Sufficient to provide such a discrete band on a TTGE gel. Clinical Samples 0064. Forty-two clinical samples tested for clonal TCR-y gene rearrangement were analyzed by the PCR/PAGE and PCR/TTGE methods. Thirty samples were peripheral blood Samples and twelve Samples were formalin-fixed paraffin embedded skin biopsies and lymph node tissues. The clinical diagnosis for each Sample was not available at the time of Sample analysis. After the Samples were analyzed by both methods, the clinical correlation for T-cell clonality of these Samples was obtained.
Example 2 DNA Extraction 0065 DNA from peripheral blood and formalin-fixed paraffin-embedded tissues was purified using Standard meth ods. 0.066 For peripheral blood samples, a white blood cell pellet was prepared through histopaque centrifugation and extracted with 1 ml DNAZol7 (Molecular Research Center, Inc., Cincinnati, Ohio, USA) at room temperature for 5 minutes. The Supernatant was collected, mixed with 0.5 ml ethanol and incubated at room temperature for 5 minutes. After centrifugation, the DNA pellet was washed twice with 75% ethanol, air-dried and dissolved in 200 ul ddH.O. 0067 For formalin-fixed tissues, three to ten 10 um thick Sections were prepared for each Sample based on the Sample size, digested with an appropriate amount of extraction buffer (50 mM Tris, 2 mM EDTA, 0.5% Tween 20 and 200 ul/ml proteinase K) at 56°C. for 3 hours and then incubated at 96° C. for 10 minutes to inactivate the proteinase. The Supernatant was collected through centrifugation and extracted using an equal Volume of phenol/chloroform. DNA was precipitated by mixing the aqueous phase with /20 volume of 5M NaCl and 2.5.x volume of ethanol and incubating at -20° C. for 30 minutes. After centrifugation, the DNA pellet was obtained, air-dried and dissolved in an appropriate amount of ddHO. The DNA samples extracted from blood were quantified using a spectrophotometer and the concentrations are adjusted to approximately 200 ng/ul. 0072 Ten microliters of the amplified TCR-Y gene prod uct were mixed with equal amount of loading buffer (0.05% Bromophenol Blue, 0.05% Xylene Cyanol, 70% Glycerol) and analyzed by 8% Novex mini polyacrylamide gel (PAGE) from Invitrogen (Carlsbad, Calif., USA) and by temporal temperature gradient gel electrophoresis (TTGE) using the DCode6 System from Bio-Rad Laboratories (Her cules, Calif., USA). 0073 For PAGE, the samples were run for 1 hour at 90 volts. PAGE analysis of the PCR products shows that 10 of the 42 samples amplified with VY1-8+JY1/2 primers yield a discrete Single band of approximately 200 bp Superimposed on a background Smear (FIG. 1) . These samples are pre Sumed to contain monoclonal T-cells. The other 32 Samples yield either a smear or a cluster of PCR products mixed with a background Smear of a Similar intensity. These Samples are classified as containing only polyclonal T-cells. 0074 For TTGE, the samples were electrophoresed for 6 hours at 90 volts on an 8% polyacrylamide gel (37.5:1) containing 1.75 M urea and 10% formamide in 1xTAE US 2004/0248172 A1 buffer (40 mM Tris base, 20 mM glacial acetic acid, 1 mM EDTA, pH 8.0). The electrophoretic temperatures are deter mined based on the melting profiles of the PCR fragments to be analyzed using WinMelto DNA melting profile analysis software from Bio-Rad Laboratories (Hercules, Calif., USA). In one run, the temperature was uniformly increased from 60° C. to 66 C. at a ramp rate of 1° C. per hour. Gels were removed, stained with ethidium bromide (1 lug/ml) for 15 min, destained with water for 1 min and photographed under UV light using ChemiImager0 4400 Alpha Imager from Alpha Innotech Corporation (San Leandro, Calif., USA). 0075 TTGE analysis of the PCR products resulted in 2 distinct patterns (FIG. 1) . The first pattern was a faint smear , Blood 86: 305-310, 1995; Menke et al., Electrophoresis 16: 733-738, 1995) . 0079) Multiple bands found on a TTGE gel should be interpreted with caution Since they may reflect the following possibilities: 1) Biallelic VJY rearrangement between Vy1-8 and JY1/2 regions analyzed with two heteroduplexes and two homoduplexes or with two homoduplexes only. The former is a typical pattern for two different DNA molecules with minor base pair substitution(s) while the latter may reflect two types of DNA molecules too distinct to form heterodu plex Structures. In one of the aspects of the present inven tion, at least two bands should display Similar Signal inten Dec. 9, 2004 sity. Similar situations have been reported by others using DGGE method (Theodorou et al., Blood 86: 305-310, 1995; Anderson et al., J. Cutan Pathol 26: 176-182, 1999) ; 2) Non-Specific PCR amplification under certain circumstances resulting in artificial DNA bands; and 3) Multi-clonal T-cell evolution in the Samples. 0080. As shown in Table 1 0083) To compare the specificity of the method of PCR/ PAGE with PCR/TTGE for detecting clonal TCR-y rear rangements, one positive sample DNA was Serially diluted two-fold with negative standard DNA. The diluted samples were then amplified by PCR and analyzed by both PAGE and TTGE (FIG. 2) .
0084. The sensitivity study shows that PCR/TTGE can detect clonal TCR-Y gene at P/N ratios as low as 10° which is equivalent to one malignant T-cell among 100 normal cells. This result is similar to that reported by Theodorou et all who tested DNA from the Jurkat T-cell line with a biallelic VY1-8+Jy1/2 and Vy 11+JY1/2 rearrangements diluted in DNA from normal skin. Using the PCR/DGGE method, Theodorou et al reported a detectable signal at 1% to 0.1% dilution range (Theodorou et al. Blood 86: 305-310, 1995) .
In the comparison of specificity between PCR/PAGE and PCR/TTGE (FIG. 2) 0089. While the invention has been described and exem plified in Sufficient detail for those skilled in this art to make and use it, various alternatives, modifications, and improve ments should be apparent without departing from the Spirit and Scope of the invention. 0090. One skilled in the art readily appreciates that the present invention is well adapted to carry out the objects and obtain the ends and advantages mentioned, as well as those inherent therein. Modifications therein and other uses will occur to those skilled in the art. These modifications are encompassed within the Spirit of the invention and are defined by the Scope of the claims. 0091. It will be readily apparent to a person skilled in the art that varying Substitutions and modifications may be made to the invention disclosed herein without departing from the Scope and Spirit of the invention.
0092 All patents and publications mentioned in the Specification are indicative of the levels of those of ordinary skill in the art to which the invention pertains. All patents and publications are herein incorporated by reference to the Same extent as if each individual publication was specifi cally and individually indicated to be incorporated by ref CCCC. 0093. The invention illustratively described herein suit ably may be practiced in the absence of any element or elements, limitation or limitations which is not specifically disclosed herein. Thus, for example, in each instance herein any of the terms "comprising", "consisting essentially of and "consisting of may be replaced with either of the other two terms. The terms and expressions which have been employed are used as terms of description and not of limitation, and there is no intention that in the use of Such terms and expressions of eXcluding any equivalents of the features shown and described or portions thereof, but it is recognized that various modifications are possible within the Scope of the invention claimed. Thus, it should be under stood that although the present invention has been Specifi cally disclosed by preferred embodiments and optional features, modification and variation of the concepts herein disclosed may be resorted to by those skilled in the art, and that Such modifications and variations are considered to be within the Scope of this invention as defined by the appended claims.
0094. In addition, where features or aspects of the inven tion are described in terms of Markush groups, those skilled in the art will recognize that the invention is also thereby described in terms of any individual member or Subgroup of members of the Markush group. For example, if X is described as Selected from the group consisting of bromine, chlorine, and iodine, claims for X being bromine and claims for X being bromine and chlorine are fully described. 0.095 Other embodiments are set forth within the follow ing claims. 
